USA: CDC approves Pfizer's COVID vaccine for kids 5 to 11 in the U.S.

.S. health officials on Tuesday gave final approval to Pfizer's kid-sized COVID-19 shot, a milestone that opens a major expansion of the nation's vaccination campaign to children as young as five.

The U.S. Food and Drug Administration (FDA) already authorized the shots for children ages five to 11 — doses just one-third of the amount given to teens and adults. But the U.S. Centers for Disease Control (CDC) formally recommends who should receive FDA-cleared vaccines.

The announcement by CDC director Dr. Rochelle Walensky came only hours after an advisory panel unanimously decided Pfizer's shots should be opened to the 28 million youngsters in that age group.

Read more at: CDC approves Pfizer's COVID vaccine for kids 5 to 11 in the U.S. | CBC News

The Netherlands to trial rapid and home coronavirus tests

Extensive research has already shown that these types of coronavirus tests are effective and reliable, and now 10 short-term trials will be used to determine whether their large-scale use is realistic or practical.

Eight of the 10 pilots will take place at educational institutions in Groningen, Delft, Amsterdam, Nijmegen, Eindhoven, Utrecht and Rotterdam, while the last two will take place at the fire station at Schiphol Airport and a private company. All trials will be supervised by Dutch hospitals and universities.

Read more at: The Netherlands to trial rapid and home coronavirus tests